logo
AI Icon𝛼SK or Search
ENTITY

Ainos (AIMD US)

41
Analysis
Information Technology • United States
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its smelltech platform, powered by AI Nose and smell language model (SLM), digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Active clinical programs include HIV-related oral warts, primary Sjögren’s syndrome, and feline chronic gingivostomatitis (FCGS). Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age.
more
Company Event • 14 Nov 2026 05:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 03 Aug 2026 19:00 • Upcoming
Add To Calendar

Q2 2026

Company Event • 10 Jun 2026 23:30 • Latest

RedChip Future Tech Investor Conference

Company Event • 14 May 2026 04:00 • Upcoming
Add To Calendar

Q1 2026

Company Event • 06 Apr 2026 19:00 • Upcoming
Add To Calendar

Investor presentation

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x